ManaMed Lidocaine 4% Pain Relieving Gel Patch

Manufacturer
Manamed, Inc.
Effective date
2025-01-09
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 20:42:44

Label at a glance#

ProductManaMed Lidocaine 4% Pain Relieving Gel Patch
Active ingredientLIDOCAINE
Label structure8 sections

Indications and uses

Temporarily relieves minor pain

Dosage and administration

Adults and children 12 years of age and over: Clean and dry affected area.Carefully remove backing from patch starting at a corner. Apply sticky side of patch to affected area.Use one patch for up to 8 hrs Children under 12 years of age : consult a physician

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Topical Anesthetic

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves minor pain

Warnings

WARNINGS SECTION

For external use only

Do not use

  • More than one patch on your body at a time 
  • On cut, irritated or swollen skin
  • On puncture wounds
  • For more than one week without consulting a doctor 
  • If you are allergic to any active or inactive ingredients 
  • If pouch is damaged or opened

When using is product

  • Use only as direacted
  • Read and follow all direactions and warnings on this carton
  • Do not allow contact with eyes
  • Do not use at the same time as other topical analgesics
  • Do not bandage tightly or apply local heat (such as heating pads)to the area of the use
  • Do not microwave
  • Dispose of used patch in the manner that always keeps product away from childen and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

Stop use and consult a doctor if

  • Condition worsens
  • Redness is present
  • Irritation develops
  • Symtoms persists for more than 7 days or clear up and occur again within a few days
  • You experience signs of skin injury, such as pain, swelling or blistering where the product was applied.

If pregnant or breastfeading, ask health professional before use.

Keep out of reach of childrenand pets If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and over:

Clean and dry affected area.Carefully remove backing from patch starting at a corner. Apply sticky side of patch to affected area.Use one patch for up to 8 hrs

Children under 12 years of age : consult a physician

Other information

SPL UNCLASSIFIED SECTION

Store in clean, dry place outside of direact sunlight. Protect from excessive moisture.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Glycerin, Propylene Glycol, PVP, Sodium Polyacrylate, Methylparaben, Propylparaben, Aluminum Glycinate, Kaolin, Polyacrylic Acid, Polysorbate 80, Tartaric Acid, Titanium Dioxide

Product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage descriptionimage descriptionimage description

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82728-001MANAMED LIDOCAINE 4% PAIN RELIEVING GEL PATCH (LIDOCAINE) PATCH [MANAMED, INC.]4Legacy NDC20250115_78d8ba4d-e9bc-40ec-9eb4-7e715ac68d5c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82728-00182728-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2b497b3c-5771-f786-e063-6294a90ad09578d8ba4d-e9bc-40ec-9eb4-7e715ac68d5c2025-01-09WarningsExact identifier
spl id: 2b497b3c-5771-f786-e063-6294a90ad095
spl set id: 78d8ba4d-e9bc-40ec-9eb4-7e715ac68d5c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.